CSL.AX लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 09:39):

Stats
आज की मात्रा	171 148
औसत मात्रा	725 457
बाजार मूल्य	132.17B
EPS	$0 ( 2024-02-13 )
Last Dividend	$1.621 ( 2023-03-09 )
Next Dividend	$0 ( N/A )
P/E	34.88
ATR14	$0.106 (0.04%)

मात्रा सहसंबंध

लंबा: -0.02 (neutral)

छोटा: -0.49 (neutral)

Signal:(60.931) Neutral

CSL Ltd सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

CSL Ltd सहसंबंध - मुद्रा/वस्त्र

-0.60
( weak negative )

-0.54
( weak negative )

0.00
( neutral )

-0.57
( weak negative )

-0.22
( neutral )

0.41
( neutral )

CSL Ltd वित्तीय

Annual	2023
राजस्व:	$19.59B
सकल लाभ:	$9.47B (48.33 %)
EPS:	$6.92

FY	2023
राजस्व:	$19.59B
सकल लाभ:	$9.47B (48.33 %)
EPS:	$6.92

FY	2022
राजस्व:	$14.47B
सकल लाभ:	$7.68B (53.05 %)
EPS:	$6.63

FY	2021
राजस्व:	$10.27B
सकल लाभ:	$5.80B (56.49 %)
EPS:	$5.22

Financial Reports:

No articles found.

CSL Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$1.758 (N/A)	$0 (N/A)	$1.621 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

CSL Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.26 - Increase likely (45.22%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0167	1994-11-08
Last Dividend	$1.621	2023-03-09
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	59	--
Total Paid Out	$28.07	--
Avg. Dividend % Per Year	0.00%	--
Score	4.48	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.26
Div. Directional Score	9.64	--

Next Divdend (Est)
(2024-06-24)

$0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

4.48

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SXE.AX	Ex Dividend Knight	2023-09-26	Annually	0.00%
CRN.AX	Ex Dividend Knight	2023-08-28	Annually	0.00%
NCC.AX	Ex Dividend Junior	2023-10-04	Semi-Annually	0.00%
WOR.AX	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
EVT.AX	Ex Dividend Knight	2023-09-13	Annually	0.00%
PIA.AX	Ex Dividend Knight	2023-08-31	Quarterly	0.00%
AOF.AX	Ex Dividend Junior	2023-06-29	Quarterly	0.00%
HUB.AX	Ex Dividend Knight	2023-09-11	Semi-Annually	0.00%
RMC.AX	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
BXB.AX	Ex Dividend Knight	2023-09-13	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.180	1.500	6.41	9.61	[0 - 0.5]
returnOnAssetsTTM	0.0696	1.200	7.68	9.21	[0 - 0.3]
returnOnEquityTTM	0.156	1.500	9.38	10.00	[0.1 - 1]
payoutRatioTTM	0.450	-1.000	5.50	-5.50	[0 - 1]
currentRatioTTM	2.15	0.800	4.25	3.40	[1 - 3]
quickRatioTTM	0.971	0.800	9.00	7.20	[0.8 - 2.5]
cashRatioTTM	0.216	1.500	9.91	10.00	[0.2 - 2]
debtRatioTTM	0.282	-1.500	5.30	-7.95	[0 - 0.6]
interestCoverageTTM	6.97	1.000	8.53	8.53	[3 - 30]
operatingCashFlowPerShareTTM	8.34	2.00	7.22	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.59	2.00	8.21	10.00	[0 - 20]
debtEquityRatioTTM	0.612	-1.500	7.55	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.484	1.000	5.26	5.26	[0.2 - 0.8]
operatingProfitMarginTTM	0.244	1.000	7.12	7.12	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.261	1.000	9.66	9.66	[0.2 - 2]
assetTurnoverTTM	0.388	0.800	-0.748	-0.599	[0.5 - 2]
Total Score				12.02

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	34.66	1.000	6.60	0	[1 - 100]
returnOnEquityTTM	0.156	2.50	9.60	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.59	2.00	8.80	10.00	[0 - 30]
dividendYielPercentageTTM	1.393	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.34	2.00	7.22	10.00	[0 - 30]
payoutRatioTTM	0.450	1.500	5.50	-5.50	[0 - 1]
pegRatioTTM	7.92	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.190	1.000	7.75	0	[0.1 - 0.5]
Total Score				7.26

CSL Ltd

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.